Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The primary objective of this clinical study is to collect clinical data to support an FDA 510(k) submission for the Nidek CEM-530 Center point method and Corner point method. The secondary objective is to evaluate any adverse events found during the clinical study.
The primary objective of this clinical study is to collect clinical data to support an FDA 510(k) submission for the Nidek CEM-530 Center point method and Corner point method.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 18-28 years old Non-pathologic | Device: Specular Microscope Nidek CEM-530 Device: Specular Microscope Konan CELLCHEK XL |
| |
| 29-80 years old Non-pathologic | Device: Specular Microscope Nidek CEM-530 Device: Specular Microscope Konan CELLCHEK XL |
| |
| 29-80 years old pathological | Device: Specular Microscope Nidek CEM-530 Device: Specular Microscope Konan CELLCHEK XL |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Specular Microscope Nidek CEM-530 | Device | Nidek CEM-530 |
|
| Measure | Description | Time Frame |
|---|---|---|
| Center Method Corneal Endothelial Cell Density | single time point - 1 day | |
| Center Method Coefficient of Variation of Endothelial Cell Area | Coefficient of variation(CV) is that Standard deviation (SD) divided by the average area of endothelial cell analyzed | single time point - 1 day |
| Percentage Hexagonality | Percentage hexagonality(%HEX) is that Proportion of hexagonal cells found in the analyzed endothelium | single time point - 1 day |
Not provided
Not provided
Inclusion Criteria:
Non-Pathologic: Male or female subjects from 18 to 80 years old who have full legal capacity to volunteer on the date the informed consent is signed. Subjects who can follow the instructions by the clinical staff at the clinical site,and can attend examinations on the scheduled examination date. Subjects who agree to participate in the study.
Pathologic: Male and female subjects from 29 to 80 years old who have full legal capacity to volunteer on the date the informed consent is signed. Subjects who can follow the instructions by the clinical staff at the clinical site, and can attend examinations on the scheduled examination date. Subjects who agree to participate in the study. At least one eye with any of the following conditions:
Exclusion Criteria:
Non-Pathologic: Male and female subjects from 29 to 80 years old who have full legal capacity to volunteer on the date the informed consent is signed. Subjects who can follow the instructions by the clinical staff at the clinical site, and can attend examinations on the scheduled examination date. Subjects who agree to participate in the study. At least one eye with any of the following conditions:
Pathologic: History of cataract, refractive or ocular surgical procedures that render the cornea opaque or otherwise impact its ability to be imaged using the investigational device. Fixation problems which may prevent obtaining at least poor quality (refer to Figure 1) CEM-530 and KONAN CELLCHEK PLUS images in either eye.
Not provided
Not provided
Ophthalmology Practice
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Gail Torkildsen, MD | Andover Eye Associates | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Andover Eye Associates | Andover | Massachusetts | 01810 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | 18-28 Years Old Non-pathologic | 18-28 years old Non-pathologic Device: Nidek CEM-530 |
| FG001 | 29-80 Years Old Non-pathologic | 29-80 years old Non-pathologic Device: Nidek CEM-530 |
| FG002 | 29-80 Years Old Pathological | 29-80 years old pathological Device: Nidek CEM-530 |
| Title | Milestones | Reasons Not Completed | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | 18-28 Years Old Non-pathologic | 18-28 years old Non-pathologic Device: Nidek CEM-530 |
| BG001 | 29-80 Years Old Non-pathologic | 29-80 years old Non-pathologic Device: Nidek CEM-530 |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Categorical | Count of Participants |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Center Method Corneal Endothelial Cell Density | Not all participants indicated in the Participant Flow Module were analysed. | Posted | Mean | Standard Deviation | cells/mm2 | single time point - 1 day |
|
1 month
Not provided
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | 18-28 Years Old Non-pathologic | Device: Nidek CEM-530 Device: Konan Specular Microscope CELLCHEK XL Specular Microscope: Nidek CEM-530 Specular Microscope: Konan CELLCHECK XL |
Not provided
Not provided
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Head, Regulatory Affairs | Nidek | (800) 223-9044 | support@nidek.com |
Not provided
| ID | Term |
|---|---|
| D055954 | Corneal Endothelial Cell Loss |
| ID | Term |
|---|---|
| D003316 | Corneal Diseases |
| D005128 | Eye Diseases |
| D005132 | Eye Manifestations |
| D011183 | Postoperative Complications |
Not provided
Not provided
Not provided
Not provided
Not provided
| Specular Microscope Konan CELLCHEK XL | Device | Konan CELLCHEK XL |
|
| BG002 | 29-80 Years Old Pathological | 29-80 years old pathological Device: Nidek CEM-530 |
| BG003 | Total | Total of all reporting groups |
| Participants |
|
| Age, Continuous | Mean | Standard Deviation | years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Region of Enrollment | Number | participants |
|
|
|
| Primary | Center Method Coefficient of Variation of Endothelial Cell Area | Coefficient of variation(CV) is that Standard deviation (SD) divided by the average area of endothelial cell analyzed | Not all participants indicated in the Participant Flow Module were analysed. | Posted | Mean | Standard Deviation | percent of Coefficient of variation | single time point - 1 day |
|
|
|
| Primary | Percentage Hexagonality | Percentage hexagonality(%HEX) is that Proportion of hexagonal cells found in the analyzed endothelium | Not all participants indicated in the Participant Flow Module were analysed. | Posted | Mean | Standard Deviation | Percentage hexagonality | single time point - 1 day |
|
|
|
| 0 |
| 28 |
| 0 |
| 28 |
| EG001 | 29-9- Years Old Non-pathologic | Device: Nidek CEM-530 Device: Konan Specular Microscope CELLCHEK XL Specular Microscope: Nidek CEM-530 Specular Microscope: Konan CELLCHECK XL | 0 | 28 | 0 | 28 |
| EG002 | 29-80 Years Old Pathological | Device: Nidek CEM-530 Device: Konan Specular Microscope CELLCHEK XL Specular Microscope: Nidek CEM-530 Specular Microscope: Konan CELLCHECK XL | 0 | 23 | 0 | 23 |
Not provided
Not provided
| D010335 |
| Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D012816 | Signs and Symptoms |